EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 68 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $15,712 | -7.8% | 17,518 | +21.2% | 0.00% | – |
| Q4 2022 | $17,049 | -85.9% | 14,448 | -10.1% | 0.00% | – |
| Q3 2022 | $121,000 | +36.0% | 16,069 | +14.3% | 0.00% | – |
| Q2 2022 | $89,000 | +17.1% | 14,061 | +22.7% | 0.00% | – |
| Q3 2021 | $76,000 | -11.6% | 11,461 | +13.4% | 0.00% | – |
| Q2 2021 | $86,000 | – | 10,104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 595,238 | $4,845,000 | 3.97% |
| P.A.W. CAPITAL CORP | 360,000 | $2,930,000 | 3.19% |
| Telemetry Investments, L.L.C. | 124,320 | $1,012,000 | 2.20% |
| Soleus Capital Management, L.P. | 472,558 | $3,847,000 | 2.04% |
| Copernicus Capital Management, LLC | 238,151 | $1,939,000 | 1.85% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $6,226,000 | 1.80% |
| Trellus Management Company, LLC | 200,000 | $1,628,000 | 1.67% |
| 683 Capital Management, LLC | 2,622,914 | $21,350,000 | 1.56% |
| KNOTT DAVID M | 275,348 | $2,241,000 | 1.32% |
| MANGROVE PARTNERS IM, LLC | 1,092,394 | $8,892,000 | 1.12% |